Uncategorized

Good news from the laboratory and a clutch of bullish analyst notes were the drivers behind Verve Therapeautics‘ (NASDAQ: VERV) big stock price leap this week. By the time the dust cleared, the biotech company’s shares soared 40% higher over the period, according to data compiled by S&P Global Market Intelligence.

Verve is a clinical-stage biotech, so its success depends on how it’s progressing with its pipeline. The indications were quite encouraging this week when the company published initial data from a phase 1b clinical trial of VERVE-102, a drug targeting heterozygous familial hypercholesterolemia (HeFH) — a genetic disorder that causes high cholesterol levels — and premature coronary artery disease.

In the trial involving 14 patents, the treatment appeared to be efficacious, particularly in reducing low-density lipoprotein cholesterol (LDL-C) levels in the body. It was also well tolerated with no serious adverse events reported.

Continue reading

Explore the exciting world of Shopify (NASDAQ: SHOP) with our expert analysts in this Motley Fool Scoreboard episode. Check out the video below to gain valuable insights into market trends and potential investment opportunities!
*Stock prices used were the prices of March 12, 2025. The video was published on April 18, 2025.

Continue reading

Rare earth miner and processor MP Materials (NYSE: MP) had quite the week to remember, both operationally and on the stock market. On the back of some quite favorable news, the company’s shares raced more than 16% higher over the course of the week, according to data compiled by S&P Global Market Intelligence.

MP Materials owns and operates the only rare earth mine in the U.S. Rare earths, for those unfamiliar, are metals that are used in the manufacture of specialty magnets used in popular high-tech products such as smartphones.

As the only native rare earth miner and processor on our shores, MP Materials has attracted much attention in the current tariff war, which has a U.S.-China standoff at its center. The Asian country has by far the highest reserves of rare earths, and last week it halted export of these materials.

Continue reading

The president is unhappy with manufacturing businesses outside of the United States.

*Stock prices used were the afternoon prices of April 12, 2025. The video was published on April 14, 2025.

Continue reading

Domino’s (NASDAQ: DPZ) offers consumers a great value proposition, which will likely improve, given the rising cost of goods.

*Stock prices used were the afternoon prices of April 12, 2025. The video was published on April 14, 2025.

Continue reading

The widely anticipated release of the latest Grand Theft Auto has investors interested in Take Two Interactive (NASDAQ: TTWO) stock.

*Stock prices used were the afternoon prices of April 12, 2025. The video was published on April 14, 2025.

Continue reading

It’s easy to love Realty Income (NYSE: O) in 2025. The S&P 500 (SNPINDEX: ^GSPC) market index is down 10% year to date on April 17. Realty Income gained 7.2%. If you reinvested the company’s monthly dividend payouts over this period, you’d have a 9.3% gain instead. The broader market’s dividends barely made a difference over the same period, lifting the S&P 500’s returns to 10.3%.

A lot of people invest in this real estate investment trust (REIT) to take advantage of that incredible dividend. There’s nothing wrong with that approach, and you can lock in some of its highest yields in history by picking up a few shares right now.

After all, the recent price gain is actually a rebound from a long period of underperformance. Realty Income took a hard hit in the lockdown phase of the COVID-19 pandemic, and the stock fell far behind the broader market over the last five years:

Continue reading

Clorox (NYSE: CLX) thrived during the pandemic but has had trouble generating growth ever since.

*Stock prices used were the afternoon prices of April 12, 2025. The video was published on April 14, 2025.

Continue reading

Few companies are as harmed by the escalating trade war between the U.S. and China as Amazon (NASDAQ: AMZN). Its massive e-commerce platform sources many goods from China, which will see a dramatic price increase as the U.S. tariff rate on goods from there now sits at 145% — at least, for the moment. However, that rate could easily change, as the two sides have not yet backed down.

While some may think that Amazon will be a casualty in this trade war, other facts dispute this claim. As a result, I think using the weakness on the tariff fears to buy Amazon stock is the smart move, as there are far more factors to Amazon than just its e-commerce business.

Let’s address the elephant in the room: Of more than 1,000 third-party sellers surveyed by ECDB, 71% said that they sourced at least one product from China. This means that there are a ton of goods on Amazon’s e-commerce platform that come from China, which could see a huge price hike shortly. In return, higher prices could cause consumers to spend less, hurting Amazon’s total e-commerce sales.

Continue reading

The stock market has been whipsawing as a result of new tariff announcements that add more complexity and uncertainty to the mix. While it appears as though President Donald Trump is enacting a more stabilizing approach with a temporary pause in place and exemptions for certain products coming into the U.S., investors are probably wondering about ways to protect their portfolios for whatever the future holds.

If you’re worried about tariffs, it might be a good idea to identify stocks that possess this one phenomenal trait.

Implementing tariffs basically increases costs that businesses face. The biggest fear among economists is that this will lead to inflationary pressures, as the higher costs are passed to consumers in the form of higher prices. People might already be aware of this possibility, as their expectations about the economy in the short term are at a 12-year low.

Continue reading